Drug Trial Radar · NCT06568042
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
558
Actual
Start
Aug 22, 2024
Primary completion
Jan 12, 2026
Study completion Apr 15, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 23, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. Participation may last up to 30 weeks including screening.
Conditions
- Neuropathic Pain
- Distal Sensory Polyneuropathy
Interventions
LY3848575Drug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change from Baseline in Average Pain Intensity Numeric Rating Scale (API-NRS)Time frame: Baseline, Week 12
Locations
76 sites in 7 countries. Site status is shown where the registry gives one.
MD First Research - Chandler
Chandler, Arizona
HOPE Research Institute
Phoenix, Arizona
Neuro-Pain Medical Center
Fresno, California
Alpine Clinical Research Center
Boulder, Colorado
Accel Research Sites - St. Pete-Largo Clinical Research Unit
Largo, Florida
Design Neuroscience Center
Miami Lakes, Florida
Conquest Research - Orlando
Orlando, Florida
Charter Research - Lady Lake
The Villages, Florida
Encore Medical Research - Weston
Weston, Florida
Conquest Research
Winter Park, Florida
Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa
Lucida Clinical Trials
New Bedford, Massachusetts
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi
StudyMetrix Research
City of Saint Peters, Missouri
Mid Hudson Medical Research
New Windsor, New York
University of Rochester Medical Center
Rochester, New York
Asheville Neurology Specialists, PA
Asheville, North Carolina
Center for Clinical Research
Winston-Salem, North Carolina
Neurology Diagnostics, Inc.
Dayton, Ohio
New Phase Research and Development
Knoxville, Tennessee
Cedar Health Research
Dallas, Texas
Biopharma Informatic, LLC
Houston, Texas
Clinical Trial Network
Houston, Texas
Northwest Clinical Research Center
Bellevue, Washington
Med Trust Research
Courtice, Canada
Dawson Clinical Research Inc.
Guelph, Canada
Premier Clinical Trial Network
Hamilton, Canada
OCT Research ULC
Kelowna, Canada
Genge Partners
Montreal, Canada
Richmond Clinical Trials
Richmond, Canada
Bluewater Clinical Research Group Inc.
Sarnia, Canada
FutureMeds GmbH
Berlin, Germany
Studienzentrum Dr. Bischof GmbH
Böblingen, Germany
Universitaetsklinikum Schleswig-Holstein Campus Kiel
Kiel, Germany
ZNS Siegen
Siegen, Germany
Studienzentrum Nord-West
Westerstede, Germany
St. Luke's International Hospital
Chūōku, Japan
Chugoku Central Hospital
Fukuyama-shi, Japan
Mito Medical Center
Higashiibaraki, Japan
Rinku General Medical Center
Izumisano, Japan
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.